EE292 Cost Effectiveness Analysis of Recombinant Zoster Vaccine Among 50 Years Old and Older in Sweden

Autor: Zarkadoulas, E., Mårdberg, K., Nishimwe, M.L., Stäck, P., Södergren, E.
Zdroj: In Value in Health December 2023 26(12) Supplement:S107-S107
Databáze: ScienceDirect